We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

This study is currently recruiting participants.
Verified July 2017 by Incyte Corporation
Sponsor:
ClinicalTrials.gov Identifier:
NCT02718300
First Posted: March 24, 2016
Last Update Posted: July 28, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Incyte Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: September 2018 (Final data collection date for primary outcome measure)